Sales of Leqembi® totaled 32.2 billion yen in the third quarter 2026
STOCKHOLM, October 28, 2026 /PRNewswire/ -- BioArctic AB's (publ) (NASDAQ Stockholm: BIOA B) partner Eisai today published the preliminary global revenue for Leqembi for the third quarter 2026, in conjunction with their partner Biogen's third quarter report. In total, sales of JPY 32.2...